menu ☰
menu ˟

FDA permits temporary distribution of losartan with higher levels of impurity

20 Mar 2019
The FDA announced that it will not object to temporary distribution of losartan that contains an amount of an impurity above an interim acceptable intake limit until it can be eliminated.Scientists with the FDA have determined that exposure to the im...

Click here to view the full article which appeared in Cardiology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.